BAY 1000394, a Novel Cyclin-Dependent Kinase Inhibitor, with Potent Antitumor Activity in Mono- and in Combination Treatment upon Oral Application

Title
BAY 1000394, a Novel Cyclin-Dependent Kinase Inhibitor, with Potent Antitumor Activity in Mono- and in Combination Treatment upon Oral Application
Authors
Keywords
-
Journal
MOLECULAR CANCER THERAPEUTICS
Volume 11, Issue 10, Pages 2265-2273
Publisher
American Association for Cancer Research (AACR)
Online
2012-07-21
DOI
10.1158/1535-7163.mct-12-0286

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now